Share this post on:

Product Name :
Brontictuzumab

Search keywords :
Brontictuzumab

drugId :
null

Target Vo:
Neurogenic locus notch homolog protein 1

Target Vo Short Name :
NOTCH1

Moa_Name:
Neurogenic locus notch homolog protein 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Oncomed Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Colorectal Neoplasms

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) site
Pepinemab manufacturer
LC3B Antibody (YA308): LC3B Antibody (YA308) is a non-conjugated and Rabbit origined monoclonal antibody about 14/16 kDa, targeting to LC3B. It can be used for WB,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related